Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Hansen

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
European Heart Journal|May 1, 1992
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial InfarctionM Vaage-Nilsen, V Rasmussen, N H Holländer, et al.
BMJ (Clinical Research Ed.)|July 20, 1996
Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction TrialS Galatius-Jensen, J Launbjerg, L S Mortensen, et al.
Danish Medical Bulletin|June 1, 1974
Pacemaker treatment. IntroductionT Haghfelt, J F Hansen, A Leth, et al.
Ugeskrift for Laeger|June 16, 1997
[Prognosis after AMI--are there gender differences?]S Galatlus-Jensen, J Launbjerg, L S Mortensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2004
Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variabilityO W Nielsen, V Rasmussen, N J Christensen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sustained-release and instant-release verapamil in treatment of angina pectorisC M Jespersen, N A Klitgaard, H Nielsen, et al.
Danish Medical Bulletin|June 1, 1974
Pacemaker treatment. V. Implanted pacemakers, function time, and complicationsA Uhrenholdt, T Haghfelt, J F Hansen, et al.
European Heart Journal|June 1, 1988
Independent prognostic risk factors for patients referred because of suspected acute myocardial infarction without confirmed diagnosis. Prognosis after discharge in relation to medical history and non-invasive investigationsJ K Madsen, B L Thomsen, K Mellemgaard, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1979
Temporal relationship between cardiac performance and myocardial uptake of dl-propranolol in manB Hesse, J F Hansen, E Steiness, et al.
Drug and Chemical Toxicology|October 23, 2001
Inhalation toxicity of tetramethylurea in ratsA J O'Neill, J F Hansen, G S Elliott, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
European Heart Journal|May 1, 1992
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial InfarctionM Vaage-Nilsen, V Rasmussen, N H Holländer, et al.
BMJ (Clinical Research Ed.)|July 20, 1996
Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction TrialS Galatius-Jensen, J Launbjerg, L S Mortensen, et al.
Danish Medical Bulletin|June 1, 1974
Pacemaker treatment. IntroductionT Haghfelt, J F Hansen, A Leth, et al.
Ugeskrift for Laeger|June 16, 1997
[Prognosis after AMI--are there gender differences?]S Galatlus-Jensen, J Launbjerg, L S Mortensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2004
Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variabilityO W Nielsen, V Rasmussen, N J Christensen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sustained-release and instant-release verapamil in treatment of angina pectorisC M Jespersen, N A Klitgaard, H Nielsen, et al.
Danish Medical Bulletin|June 1, 1974
Pacemaker treatment. V. Implanted pacemakers, function time, and complicationsA Uhrenholdt, T Haghfelt, J F Hansen, et al.
European Heart Journal|June 1, 1988
Independent prognostic risk factors for patients referred because of suspected acute myocardial infarction without confirmed diagnosis. Prognosis after discharge in relation to medical history and non-invasive investigationsJ K Madsen, B L Thomsen, K Mellemgaard, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1979
Temporal relationship between cardiac performance and myocardial uptake of dl-propranolol in manB Hesse, J F Hansen, E Steiness, et al.
Drug and Chemical Toxicology|October 23, 2001
Inhalation toxicity of tetramethylurea in ratsA J O'Neill, J F Hansen, G S Elliott, et al.
Pageof 17